Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Prelude Therapeutics Inc stock
Learn how to easily invest in Prelude Therapeutics Inc stock.
Prelude Therapeutics Inc is a biotechnology business based in the US. Prelude Therapeutics Inc shares (PRLD) are listed on the NASDAQ and all prices are listed in US Dollars. Prelude Therapeutics Inc employs 120 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy Prelude Therapeutics Inc stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – PRLD. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
- Get free stock upon signup
- Earn 4% interest on uninvested cash with Robinhood Gold
- Get 1% match on contributions to a Robinhood IRA
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.
Prelude Therapeutics Inc stock price (NASDAQ: PRLD)Use our graph to track the performance of PRLD stocks over time.
Prelude Therapeutics Inc shares at a glance
|Latest market close||$6.07|
|52-week range||$3.87 - $10.72|
|50-day moving average||$6.02|
|200-day moving average||$6.05|
|Wall St. target price||$9.60|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-2.58|
Buy Prelude Therapeutics Inc stocks from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Prelude Therapeutics Inc stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Prelude Therapeutics Inc price performance over time
|1 week (2023-01-25)||-17.30%|
|1 month (2022-12-30)||0.50%|
|3 months (2022-11-01)||-8.72%|
|6 months (2022-08-01)||20.20%|
|1 year (2022-01-28)||-37.29%|
|2 years (2021-02-01)||-91.26%|
|3 years (2020-01-28)||N/A|
|5 years (2018-01-28)||N/A|
Prelude Therapeutics Inc financials
|Gross profit TTM||$0|
|Return on assets TTM||-26.84%|
|Return on equity TTM||-45.26%|
|Market capitalisation||$347.8 million|
TTM: trailing 12 months
Prelude Therapeutics Inc share dividends
We're not expecting Prelude Therapeutics Inc to pay a dividend over the next 12 months.
Prelude Therapeutics Inc share price volatility
Over the last 12 months, Prelude Therapeutics Inc's shares have ranged in value from as little as $3.87 up to $10.72. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Prelude Therapeutics Inc's is 0.3706. This would suggest that Prelude Therapeutics Inc's shares are less volatile than average (for this exchange).
To put Prelude Therapeutics Inc's beta into context you can compare it against those of similar companies.
- Kura Oncology (KURA.US): 0.8322
- Inovio Pharmaceuticals (INO.US): 1.0684
- EXACT Sciences Corporation (EXAS.US): 1.3331
Prelude Therapeutics Inc overview
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid tumors, including glioblastoma multiforme. The company is also developing PRT1419, a potent and selective inhibitor of the anti-apoptotic protein; PRT2527, a potent inhibitor of CDK9 that exhibits high kinome selectivity; PRT-SCA2, which is in preclinical stage for multiple genomically selected cancers; PRT3645, a brain penetrant molecule that potently and selectively targets CDK4/6; and PRT-K4 that is in preclinical stage for solid tumors. The company was incorporated in 2016 and is headquartered in Wilmington, Delaware. .
Prelude Therapeutics Inc in the news
We're Not Very Worried About Prelude Therapeutics' (NASDAQ:PRLD) Cash Burn Rate
Frequently asked questionsWhat percentage of Prelude Therapeutics Inc is owned by insiders or institutions?
Currently 7.399% of Prelude Therapeutics Inc shares are held by insiders and 78.631% by institutions. How many people work for Prelude Therapeutics Inc?
Latest data suggests 120 work at Prelude Therapeutics Inc. When does the fiscal year end for Prelude Therapeutics Inc?
Prelude Therapeutics Inc's fiscal year ends in December. Where is Prelude Therapeutics Inc based?
Prelude Therapeutics Inc's address is: 200 Powder Mill Road, Wilmington, DE, United States, 19803 What is Prelude Therapeutics Inc's ISIN number?
Prelude Therapeutics Inc's international securities identification number is: US74065P1012
More guides on Finder
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
How to research stocks
Learn about stock analysis and how to use it to find the right company to buy.
Ask an Expert